The arrangement serves as a case study for how outreach agreements can help hospital systems expand patient access to ...
Synovial sarcoma is a rare, aggressive malignancy with deceptive benign presentation, complicating diagnosis and delaying treatment. Molecular confirmation of SS18-SSX fusion genes is crucial for ...
As clinical diagnostics become a central force in shaping therapies and driving innovation, healthcare leaders must prepare ...
DELFI leadership to announce advancement with whole-genome machine learning for lung cancer detection test at HLTH 2023; Presentation of DELFI's L101 clinical validation study at CHEST Annual Meeting ...
NEW YORK, April 24, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (LUCD) (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of ...
New study reveals that large language models outperform physicians in diagnostic accuracy but require strategic integration to enhance clinical decision-making without replacing human expertise. Study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback